http://www.twitter.comTwitter is a service for friends, family, and co-workers to communicate and stay connected through the exchange of quick, frequent answers to one simple question: What are you doing?
View Older Stories View More Recent Stories
-
Cryoport Expands Global Supply Chain Network with Belgium Acquisition
-
LabConnect and Cryoport Partner to Provide Support for Innovative Triumvira Cell and Gene Therapy Clinical Trial
-
Cryoport and CCRM Fertility Enter Into Agreement
-
Cryoport Reports 2020 Third-Quarter Results
-
Cryoport to Report Third Quarter 2020 Financial Results on November 5, 2020
-
Cryoport Completes Acquisitions of MVE Biological Solutions and CRYOPDP
-
Cryoport Announces Agreement to Acquire MVE Biological Solutions from Chart Industries
-
Cryoport (CYRX) Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
-
Cryoport Expands Global Supply Chain Platform by Signing Agreement to Acquire CRYOPDP
-
Cryoport Reports 2020 Second-Quarter Results
-
MEDIPAL HOLDINGS Partners with CRYOPORT to Bring Temperature-Controlled Supply Chain Solutions to the Japanese Market
-
Cryoport to Report Second Quarter 2020 Financial Results on August 6, 2020
-
Cryoport Revenue Grows 47% for First Quarter 2020
-
/C O R R E C T I O N -- Cryoport, Inc./
-
Cryoport to Report First Quarter 2020 Financial Results on May 7, 2020
-
Cryoport Reports Record Revenue for Fiscal Year 2019
-
Cryoport to Report Fourth Quarter and Fiscal Year 2019 Financial Results on March 5, 2020
-
Cryoport and Inception Fertility Enter Into Agreement
-
Cryoport (CYRX) Announces Preliminary Q4 Revenue
-
Cryoport Announces Preliminary Fourth Quarter and Full Year 2019 Revenue
-
Cryoport Revenue Grows 81% for Third Quarter 2019
-
Lonza Partners with Cryoport and Strengthens its 'Vein-to-vein' Delivery Network in Cell & Gene Therapy
-
Cryoport to Report Third Quarter 2019 Financial Results on November 7, 2019
-
Cryoport (CYRX) Authorizes $15M Share Repurchase Program
-
Cryoport Authorizes Share Repurchase Program and Presenting at Upcoming Investor Conferences
-
Adaptimmune and Cryoport Announce Agreement to Ensure Safe and Fully Monitored Transport of Adaptimmune’s Cell Therapies
-
Cryoport Introduces Cell & Gene Industry's First Dedicated Shipper for Advanced Therapies
-
Vineti and Cryoport Collaborate to Bring Integrated Solutions to the Global Regenerative Therapy Market
-
Cryoport Revenue Grows 83% for Second Quarter 2019
-
Cryoport to Report Second Quarter 2019 Financial Results on August 8th, 2019
-
Cryoport (CYRX), EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
-
Cryoport and EVERSANA Form Strategic Alliance to Accelerate Regenerative Medicine Supply Chain
-
Cryoport to Ring the Nasdaq Closing Bell on Monday, June 10 and Attend Jefferies 2019 Healthcare Conference June 4ᵗʰ-7ᵗʰ, 2019
-
CalAmp Announces Research Collaboration with Cryoport to Develop Next Generation Condition Monitoring System
-
Cryoport (CYRX) Reports Acquisition of Cryogene
-
Cryoport Expands into Biostorage through the Acquisition of Cryogene
-
Cryoport to Host Workshop at 14th Annual World Advanced Therapies & Regenerative Medicine Congress on Wednesday, May 15th
-
Cryoport Revenue Grows 65% for First Quarter 2019
-
Cryoport to Report First Quarter 2019 Financial Results on May 2nd, 2019
-
Celularity Selects Cryoport's Temperature Controlled Logistics Solutions
-
Biokin Pharmaceutical Selects Cryoport's Temperature-Controlled Solutions for its Pending Phase I and Phase II trials
-
Cryoport Reports 64% Growth for Fiscal Year 2018
-
Cryoport to Report Fourth Quarter and Fiscal Year 2018 Financial Results on March 7th, 2019
-
Cryoport Opens Global Logistics Center in Amsterdam
-
Dacos A/S Partners with Cryoport to Offer Full Suite of Temperature-Controlled Logistics Solutions to Global Client Base
-
Cryoport (CYRX) Announces Daniel M. Hancock to Board
-
Cryoport Appoints Daniel M. Hancock to Board of Directors
-
Cryoport Announces $25 Million Investment from Petrichor Healthcare Capital Management
-
Cryoport Revenue Grows 76% for Third Quarter 2018; 91% Growth in Biopharma
-
Cryoport to Report Third Quarter 2018 Financial Results on November 8th, 2018

